Guaifenesin Patent Expiration
Guaifenesin is Used for treating respiratory conditions by promoting the expulsion of mucus from the lungs. It was first introduced by Rb Health Us Llc
Guaifenesin Patents
Given below is the list of patents protecting Guaifenesin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mucinex | US6372252 | Guaifenesin sustained release formulation and tablets |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex | US6955821 | Sustained release formulations of guaifenesin and additional drug ingredients |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex | US7838032 | Sustained release of guaifenesin |
Apr 28, 2020
(Expired) | Rb Hlth |
Guaifenesin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List